144 related articles for article (PubMed ID: 23544270)
1. DPP4 genetic variants influence baseline prostate-specific antigen levels: the J-MICC study.
Higashibata T; Naito M; Mori A; Ozawa N; Furuta M; Tsuchiya R; Koyama E; Morita E; Kawai S; Okada R; Yin G; Wakai K; Hamajima N
Nagoya J Med Sci; 2013 Feb; 75(1-2):73-80. PubMed ID: 23544270
[TBL] [Abstract][Full Text] [Related]
2. Association between KLK3 rs2735839 G/A polymorphism and serum PSA levels in Japanese men.
Nobata S; Hishida A; Naito M; Asai Y; Mori A; Kuwabara M; Katase S; Okada R; Morita E; Kawai S; Hamajima N; Wakai K
Urol Int; 2012; 89(1):39-44. PubMed ID: 22433834
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study of serum prostate-specific antigen levels based on 1000 Genomes imputed data in Japanese: the Japan Multi-Institutional Collaborative Cohort Study.
Hishida A; Nakatochi M; Tamura T; Nagayoshi M; Okada R; Kubo Y; Tsukamoto M; Kadomatsu Y; Suzuki S; Nishiyama T; Kuriyama N; Watanabe I; Takezaki T; Nishimoto D; Kuriki K; Arisawa K; Katsuura-Kamano S; Mikami H; Kusakabe M; Oze I; Koyanagi YN; Nakamura Y; Kadota A; Shimanoe C; Tanaka K; Ikezaki H; Murata M; Kubo M; Momozawa Y; Takeuchi K; Wakai K;
Nagoya J Med Sci; 2021 Feb; 83(1):183-194. PubMed ID: 33727749
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer.
Wen YC; Lin CY; Hsiao CH; Wang SS; Huang HC; Lin YW; Ho KH; Chang LC; Yang SF; Chien MH
J Cell Mol Med; 2023 Sep; 27(17):2507-2516. PubMed ID: 37533175
[TBL] [Abstract][Full Text] [Related]
5. Association of dipeptidyl peptidase IV polymorphism with clinicopathological characters of oral cancer.
Chen PJ; Lu HJ; Nassef Y; Lin CW; Chuang CY; Lee CY; Chiu YW; Yang SF; Yang WE
J Oral Pathol Med; 2022 Sep; 51(8):730-737. PubMed ID: 35880802
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population.
Sun J; Tao S; Gao Y; Peng T; Tan A; Zhang H; Yang X; Qin X; Hu Y; Feng J; Kim ST; Lin X; Wu Y; Zhang J; Li Z; Li L; Mo L; Liang Z; Shi D; Huang Z; Huang X; Liu M; Liu Q; Zhang S; Lilly Zheng S; Xu J; Mo Z
Hum Genet; 2013 Apr; 132(4):423-9. PubMed ID: 23269536
[TBL] [Abstract][Full Text] [Related]
7. Association between DPP4 gene polymorphism and serum lipid levels in Chinese type 2 diabetes individuals.
Xing X; Han Y; Zhou X; Zhang B; Li Y; Wang Z; Liao L; Su L
Neuropeptides; 2016 Dec; 60():1-6. PubMed ID: 27585937
[TBL] [Abstract][Full Text] [Related]
8. Association of DPP4 Gene Polymorphisms with Type 2 Diabetes Mellitus in Malaysian Subjects.
Ahmed RH; Huri HZ; Al-Hamodi Z; Salem SD; Al-Absi B; Muniandy S
PLoS One; 2016; 11(4):e0154369. PubMed ID: 27111895
[TBL] [Abstract][Full Text] [Related]
9. Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.
Cramer SD; Chang BL; Rao A; Hawkins GA; Zheng SL; Wade WN; Cooke RT; Thomas LN; Bleecker ER; Catalona WJ; Sterling DA; Meyers DA; Ohar J; Xu J
J Natl Cancer Inst; 2003 Jul; 95(14):1044-53. PubMed ID: 12865450
[TBL] [Abstract][Full Text] [Related]
10. Association of dipeptidyl peptidase IV polymorphism, serum lipid profile, and coronary artery stenosis in patients with coronary artery disease and type 2 diabetes.
Wang Z; Liu Y; Wang W; Qu H; Han Y; Hou Y
Medicine (Baltimore); 2021 Apr; 100(13):e25209. PubMed ID: 33787603
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants at 1q32.1, 10q11.2 and 19q13.41 are associated with prostate-specific antigen for prostate cancer screening in two Korean population-based cohort studies.
Kim S; Shin C; Jee SH
Gene; 2015 Feb; 556(2):199-205. PubMed ID: 25434496
[TBL] [Abstract][Full Text] [Related]
12. Variant of the clock circadian regulator (CLOCK) gene and related haplotypes are associated with the prevalence of type 2 diabetes in the Japanese population.
Uemura H; Katsuura-Kamano S; Yamaguchi M; Arisawa K; Hamajima N; Hishida A; Kawai S; Oze I; Shinchi K; Takashima N; Suzuki S; Nakahata N; Mikami H; Ohnaka K; Kuriyama N; Kubo M; Tanaka H;
J Diabetes; 2016 Sep; 8(5):667-76. PubMed ID: 26374515
[TBL] [Abstract][Full Text] [Related]
13. Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study.
Grönberg H; Adolfsson J; Aly M; Nordström T; Wiklund P; Brandberg Y; Thompson J; Wiklund F; Lindberg J; Clements M; Egevad L; Eklund M
Lancet Oncol; 2015 Dec; 16(16):1667-76. PubMed ID: 26563502
[TBL] [Abstract][Full Text] [Related]
14. Association of KLK3 (PSA) genetic variants with prostate cancer risk and PSA levels.
Penney KL; Schumacher FR; Kraft P; Mucci LA; Sesso HD; Ma J; Niu Y; Cheong JK; Hunter DJ; Stampfer MJ; Hsu SI
Carcinogenesis; 2011 Jun; 32(6):853-9. PubMed ID: 21421545
[TBL] [Abstract][Full Text] [Related]
15. A "PSA pyramid" for men with initial prostate-specific antigen ≤3 ng/ml: a plea for individualized prostate cancer screening.
Randazzo M; Beatrice J; Huber A; Grobholz R; Manka L; Chun FK; Recker F; Kwiatkowski M
Eur Urol; 2015 Oct; 68(4):591-7. PubMed ID: 24794075
[TBL] [Abstract][Full Text] [Related]
16. A genome-wide association study of serum levels of prostate-specific antigen in the Japanese population.
Terao C; Terada N; Matsuo K; Kawaguchi T; Yoshimura K; Hayashi N; Shimizu M; Soga N; Takahashi M; ; Kotoura Y; Yamada R; Ogawa O; Matsuda F
J Med Genet; 2014 Aug; 51(8):530-6. PubMed ID: 24919509
[TBL] [Abstract][Full Text] [Related]
17. A replication study examining three common single-nucleotide polymorphisms and the risk of prostate cancer in a Japanese population.
Liu M; Suzuki M; Arai T; Sawabe M; Enomoto Y; Nishimatsu H; Kume H; Homma Y; Kitamura T
Prostate; 2011 Jul; 71(10):1023-32. PubMed ID: 21557267
[TBL] [Abstract][Full Text] [Related]
18. Optimal screening interval for men with low baseline prostate-specific antigen levels (≤1.0 ng/mL) in a prostate cancer screening program.
Urata S; Kitagawa Y; Matsuyama S; Naito R; Yasuda K; Mizokami A; Namiki M
World J Urol; 2017 Apr; 35(4):579-586. PubMed ID: 27421271
[TBL] [Abstract][Full Text] [Related]
19. The Stockholm-3 Model for Prostate Cancer Detection: Algorithm Update, Biomarker Contribution, and Reflex Test Potential.
Ström P; Nordström T; Aly M; Egevad L; Grönberg H; Eklund M
Eur Urol; 2018 Aug; 74(2):204-210. PubMed ID: 29331214
[TBL] [Abstract][Full Text] [Related]
20. Interim Results from the IMPACT Study: Evidence for Prostate-specific Antigen Screening in BRCA2 Mutation Carriers.
Page EC; Bancroft EK; Brook MN; Assel M; Hassan Al Battat M; Thomas S; Taylor N; Chamberlain A; Pope J; Raghallaigh HN; Evans DG; Rothwell J; Maehle L; Grindedal EM; James P; Mascarenhas L; McKinley J; Side L; Thomas T; van Asperen C; Vasen H; Kiemeney LA; Ringelberg J; Jensen TD; Osther PJS; Helfand BT; Genova E; Oldenburg RA; Cybulski C; Wokolorczyk D; Ong KR; Huber C; Lam J; Taylor L; Salinas M; Feliubadaló L; Oosterwijk JC; van Zelst-Stams W; Cook J; Rosario DJ; Domchek S; Powers J; Buys S; O'Toole K; Ausems MGEM; Schmutzler RK; Rhiem K; Izatt L; Tripathi V; Teixeira MR; Cardoso M; Foulkes WD; Aprikian A; van Randeraad H; Davidson R; Longmuir M; Ruijs MWG; Helderman van den Enden ATJM; Adank M; Williams R; Andrews L; Murphy DG; Halliday D; Walker L; Liljegren A; Carlsson S; Azzabi A; Jobson I; Morton C; Shackleton K; Snape K; Hanson H; Harris M; Tischkowitz M; Taylor A; Kirk J; Susman R; Chen-Shtoyerman R; Spigelman A; Pachter N; Ahmed M; Ramon Y Cajal T; Zgajnar J; Brewer C; Gadea N; Brady AF; van Os T; Gallagher D; Johannsson O; Donaldson A; Barwell J; Nicolai N; Friedman E; Obeid E; Greenhalgh L; Murthy V; Copakova L; Saya S; McGrath J; Cooke P; Rønlund K; Richardson K; Henderson A; Teo SH; Arun B; Kast K; Dias A; Aaronson NK; Ardern-Jones A; Bangma CH; Castro E; Dearnaley D; Eccles DM; Tricker K; Eyfjord J; Falconer A; Foster C; Gronberg H; Hamdy FC; Stefansdottir V; Khoo V; Lindeman GJ; Lubinski J; Axcrona K; Mikropoulos C; Mitra A; Moynihan C; Rennert G; Suri M; Wilson P; Dudderidge T; ; Offman J; Kote-Jarai Z; Vickers A; Lilja H; Eeles RA
Eur Urol; 2019 Dec; 76(6):831-842. PubMed ID: 31537406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
